GlassScriptPhysician profile
Brian Montevirgen
NPI 1750735080
$559.39
in general payments reported to CMS, 2019-2025
9 companies · $120 in 2025
The $120 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.21 · 2020: $49.72 · 2021: $64.68 · 2023: $74.57 · 2024: $223 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $417.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $202.59 | 2019-2024 | Bexsero |
| Kowa Pharmaceuticals America, INC. | $84.46 | 2025 | Zoryve |
| Aytu Biopharma, INC. | $61.40 | 2024-2025 | Karbinal |
| Sanofi Pasteur INC. | $52.63 | 2023-2024 | |
| Pfizer INC. | $43.14 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $41.52 | 2021 | |
| Sobi, INC | $31.31 | 2023 | |
| Genentech USA, INC. | $22.50 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $19.84 | 2025 | Kristalose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Montevirgen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.